Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 13 results found. Search for [ Eli Lilly Regeneron ]

Results 1 to 13 of 13
Reuters
November 11, 2020
The Food and Drug Administration (FDA) granted emergency use authorization (EUA) to Eli Lilly & Co's bamlanivimab based on trial data


PTI
October 31, 2020
Regeneron Pharmaceuticals Inc. said Friday that independent monitors had recommended placing on hold enrollment of the most severely ill patients


BusinessToday.In
October 30, 2020
The company said that it has been listed ahead of global pharma companies such as Roche, Eli Lilly, Abbott, Novartis, and Pfizer in this year's rankings


Reuters
October 27, 2020
President Donald Trump received a similar experimental antibody drug from Regeneron Pharmaceuticals Inc on an emergency basis when he was sickened with the coronavirus earlier this month


Reuters
October 16, 2020
The American company said the data appeared inconsistent, the findings were premature and that other studies had validated the drug's benefits


PTI
October 14, 2020
Trump, who tested positive for COVID-19 on October 1 and was admitted to a military hospital for three nights and four days, declared himself cured after he was treated with an experimental antibody drug cocktail


BusinessToday.In
October 14, 2020
Dr Reddy's has teamed up with Russian Development Investment Fund (RDIF) to conduct trials and distribute 100 million doses of Sputnik V in India


Reuters
October 14, 2020
Trump touted the Lilly drug, along with the antibody treatment from Regeneron Pharmaceuticals Inc that he received for his COVID-19, as tantamount to a cure in a video he posted last week


Reuters
October 10, 2020
The agreement, under the Trump administration's Operation Warp Speed, is for developing a monoclonal antibody cocktail that can prevent COVID-19


PTI
October 8, 2020
Trump was admitted to Walter Reed National Medical Center last Friday, a day after he and First Lady Melania Trump tested positive for COVID-19


Reuters
August 4, 2020
The Phase III trial is expected to enroll up to 2,400 participants who live or work at facilities that have had a recently diagnosed case of COVID-19


PB Jayakumar
June 11, 2020
While two such therapies have entered the human clinical trial phase, more are expected in the coming weeks


PB Jayakumar
April 29, 2020
Biocon is developing a customised non-replicating measles virus based vaccine for coronavirus, a latest antigen therapy that can be commercialised quickly, along with two new generation repurposed drugs and an antibody diagnostic kit


PAGES 1 OF 1